Effect of perioperative intravenous lidocaine infusion on postoperative early recovery quality in patients undergoing upper airway surgery: a randomized controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022109

Enrollment

Unknown

Registered

2019-03-25

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Airway Surgery

Interventions

Lidocaine group:?????

Saline control group:???????

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA I-II, patients aged 18-65 years undergoing elective Upper airway surgery.

Exclusion criteria

Exclusion criteria: Exclusion criteria were patients with relative or absolute contraindication to the use of lidocaine (allergy to local anesthetics), changes in atrioventricular conduction, severe liver and kidney dysfunction, uncontrolled hypertension, mentally disturbed or unable to cooperate, and malignant hyperthermia, those receiving antidepressants and/ or anticonvulsants, with cardiac arrhythmia and alcohol addiction history, patients who do not understand QoR-40 and/ or have used opioids in the past 24 hours.

Design outcomes

Primary

Measure	Time frame
QoR-40;	—

Secondary

Measure	Time frame
Sufentanil and Remifentanil consumption;Visual Analogue Scale (VAS);Incidence of PONV;Anesthesia time;Extubation time;Length of PACU stay;	—

Countries

China

Contacts

Public ContactChenglan Xie

xiechenglan@163.com+86 13776701556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026